Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jonathan Schneck
Johns Hopkins University, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
NexImmune, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The SFIs that result from the intellectual property rights and equity interest are related in that their value could be affected by the research. The SFI that results from the fiduciary role is related in that it is in an entity whose financial interest could be affected by the research. Upon review by the institution, it was determined that Dr. Schneck’s SFIs could directly and significantly affect the design, conduct or reporting of his research under this award.
Antigen-specific T cell Redirectors, ATR, for immunotherapy
The research is relevant to public health as the proposed experiments will address development of a new approach for treatment of hematological malignancies using a nanoparticle based approach redirecting antigen-specific cytotoxic T cells to kill human lymphoma cells. If successful, this approach can be used for redirecting lysis of other cancers and immune modulation in general. Thus, the proposed research is relevant to the part of NIH's mission that pertains to enhancing fundamental knowledge that will impact on immune therapy for cancer and other diseases.
Filed on January 05, 2018.
Tell us what you know about Jonathan Schneck's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Jonathan Schneck filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jonathan Schneck | Johns Hopkins University | Conflict of Interest | NexImmune, Inc. | Value cannot be readily determined |
| Jonathan Schneck | Johns Hopkins University | Conflict of Interest | NexImmune, Inc. | Value cannot be readily determined |
| Jonathan Schneck | Johns Hopkins University | Conflict of Interest | NexImmune, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.